Core Insights - Sotera Health Company (SHC) is showing potential as a technical investment due to reaching a key support level and experiencing a "golden cross" where the 50-day simple moving average crossed above the 200-day simple moving average, indicating a possible bullish breakout [1] Technical Analysis - A golden cross consists of three stages: a downtrend that bottoms out, a shorter moving average crossing above a longer moving average, and continued upward momentum in stock prices [2] - The occurrence of a golden cross suggests a positive trend reversal, contrasting with a death cross which indicates potential bearish movement [2] Performance Metrics - Over the past four weeks, SHC has experienced a significant gain of 35.1%, and currently holds a 3 (Hold) rating on the Zacks Rank, suggesting the stock may be on the verge of a breakout [3] - Recent earnings expectations have improved, with two upward revisions and no downward changes in estimates over the past 60 days, further supporting the bullish outlook [3] Investment Consideration - Given the important technical indicators and positive earnings estimate movements, SHC is recommended for inclusion on investors' watchlists [5]

Technical Analysis - InfuSystems Holdings, Inc. (INFU) has reached a significant support level, indicating a potential investment opportunity from a technical perspective [1] - A "golden cross" has occurred, with INFU's 50-day simple moving average breaking above its 200-day moving average, suggesting a potential bullish breakout [1] - The golden cross pattern typically indicates a strong breakout due to the crossover of short-term and long-term moving averages [1][2] Stock Performance - INFU shares have increased by 69.3% over the past four weeks, indicating strong upward momentum [3] - The company currently holds a 1 (Strong Buy) rating on the Zacks Rank, further suggesting a potential breakout [3] Earnings Outlook - There have been no earnings estimate cuts for the current quarter, with one revision higher in the past 60 days, indicating a positive earnings outlook [3] - The Zacks Consensus Estimate for INFU has also increased, reinforcing the bullish sentiment around the stock [3] Investment Consideration - Given the technical indicators and positive earnings estimates, investors are encouraged to consider adding INFU to their watchlist [5]

Technical Analysis - TEGNA Inc. (TGNA) has reached a significant support level, indicating a potential investment opportunity from a technical perspective [1] - A "golden cross" has occurred, where TGNA's 50-day simple moving average has broken above its 200-day moving average, suggesting a bullish breakout may be imminent [1] - The golden cross pattern typically indicates stronger breakouts due to the involvement of longer time periods [1] Market Performance - TGNA has experienced a rally of 24.8% over the past four weeks, indicating positive momentum [3] - The company currently holds a 3 (Hold) rating on the Zacks Rank, suggesting it could be poised for further breakout [3] Earnings Outlook - There have been no cuts to earnings estimates for the current quarter, with one revision higher in the past 60 days, indicating a positive earnings outlook [3] - The Zacks Consensus Estimate for TGNA has also increased, further solidifying the bullish case for the company [3] Investment Consideration - Given the technical indicators and positive movement in earnings estimates, investors are encouraged to consider adding TGNA to their watchlist [5]

Core Viewpoint - CPB Inc. (CPF) has reached a significant support level and is considered a good investment opportunity from a technical perspective due to the recent "golden cross" formation [1] Technical Analysis - CPF's 50-day simple moving average has broken above its 200-day moving average, indicating a bullish breakout [1] - A golden cross is characterized by a downtrend followed by a crossover of the shorter moving average over the longer one, leading to a potential trend reversal [2] Performance Metrics - CPF has experienced a rally of 13.2% over the past four weeks, suggesting positive momentum [3] - The company currently holds a 3 (Hold) rating on the Zacks Rank, indicating potential for further gains [3] Earnings Outlook - Positive earnings outlook for the current quarter, with no downward revisions in earnings estimates over the past two months and an increase in the Zacks Consensus Estimate [3][4] - The combination of earnings estimate revisions and technical indicators suggests that CPF may continue to see gains in the near future [4]

Core Viewpoint - Enerflex Ltd. (EFXT) is showing potential for a bullish breakout due to a recent "golden cross" in its moving averages, indicating a key level of support has been reached [1]. Technical Indicators - EFXT's 50-day simple moving average has crossed above its 200-day simple moving average, forming a "golden cross," which is a bullish technical chart pattern [1]. - A successful golden cross event consists of three stages: a price decline bottoming out, the shorter moving average crossing above the longer moving average, and the stock maintaining upward momentum [2]. Performance Metrics - Over the past four weeks, EFXT has gained 20%, indicating strong performance [3]. - The stock currently holds a 2 (Buy) rating on the Zacks Rank, suggesting it may be poised for further breakout [3]. Earnings Outlook - EFXT's earnings outlook is positive, with no earnings estimates cut for the current quarter and two revisions higher in the past 60 days [3]. - The Zacks Consensus Estimate for EFXT has also increased, reinforcing the bullish sentiment [3]. Investment Consideration - Given the technical indicators and positive earnings estimates, investors are encouraged to consider adding EFXT to their watchlist [5].

Group 1 - ScanSource, Inc. (SCSC) has reached an important support level and recently experienced a "golden cross" event, indicating a potential bullish breakout [1][2] - A golden cross occurs when a stock's short-term moving average, typically the 50-day, crosses above its long-term moving average, usually the 200-day, suggesting stronger breakouts [2][3] - SCSC has rallied 7.8% over the past four weeks and currently holds a 1 (Strong Buy) rating on the Zacks Rank, indicating a strong bullish sentiment [4] Group 2 - The positive earnings outlook for SCSC further supports the bullish case, with no earnings estimates decreasing in the past two months and two revisions higher [4][6] - The Zacks Consensus Estimate for SCSC has increased, reinforcing the potential for further gains in the near future [6]

Group 1 - Backblaze, Inc. (BLZE) has reached a key level of support, with its 50-day simple moving average crossing above the 200-day simple moving average, indicating a "golden cross" which is a bullish signal for potential breakout [1] - The golden cross consists of three stages: a downtrend that bottoms out, the shorter moving average crossing above the longer moving average, and the stock continuing to rise [2] - Over the past four weeks, BLZE has gained 50.8%, and it currently holds a 2 (Buy) rating on the Zacks Rank, suggesting a strong bullish case [3] Group 2 - The positive earnings outlook for BLZE is supported by four upward revisions in earnings estimates over the past 60 days, with no downward revisions, indicating a favorable trend [3] - Investors are encouraged to consider adding BLZE to their watchlist due to the significant technical indicator and the positive movement in earnings estimates [5]

Core Viewpoint - SiteOne Landscape Supply, Inc. (SITE) is showing potential for a bullish breakout as it has reached a key support level and experienced a "golden cross" in its moving averages [1][2]. Technical Analysis - A golden cross occurs when a short-term moving average, such as the 50-day, crosses above a longer-term moving average, like the 200-day, indicating a potential bullish trend [2]. - The golden cross consists of three stages: a downtrend that bottoms out, the crossover of moving averages, and an upward price movement [3]. Stock Performance - SITE's shares have increased by 10.9% over the past four weeks, indicating positive momentum [4]. - The company holds a 2 (Buy) rating on the Zacks Rank, suggesting it may be positioned for further gains [4]. Earnings Outlook - The earnings outlook for SITE is positive, with no downward revisions in earnings estimates over the past two months and three upward revisions, leading to an increase in the Zacks Consensus Estimate [4][5]. - Given the positive technical indicators and earnings estimate movements, SITE may present a favorable investment opportunity [5].

Core Viewpoint - Aveanna Healthcare Holdings Inc. (AVAH) is showing potential for a bullish breakout due to a recent technical indicator known as a "golden cross" [1][2]. Technical Analysis - AVAH's 50-day simple moving average has crossed above its 200-day simple moving average, indicating a bullish signal [1]. - A golden cross typically follows a downtrend, leading to a positive trend reversal and subsequent upward momentum [2]. Performance Metrics - AVAH has experienced a significant rally of 88.6% over the past four weeks, suggesting strong market interest [3]. - The company currently holds a 1 (Strong Buy) rating on the Zacks Rank, indicating favorable market conditions for potential gains [3]. Earnings Outlook - The earnings outlook for AVAH is positive, with no downward revisions in earnings estimates over the past two months, alongside four upward revisions [3]. - The Zacks Consensus Estimate for earnings has also increased, reinforcing the bullish sentiment around the stock [3][5]. Investment Consideration - Given the combination of positive earnings revisions and the technical breakout signal, AVAH is positioned for potential further gains in the near future [5].

Core Insights - Johnson & Johnson's stock has been performing well, trading above its 50-day and 200-day simple moving averages since mid-June, achieving a golden cross in mid-July after strong Q2 2025 results and raised guidance [1][8]. Group 1: Business Model and Performance - Johnson & Johnson's diversified business model is a significant strength, operating in both medical devices and pharmaceuticals, with over 275 subsidiaries [6][7]. - The Innovative Medicine unit is showing growth, with a 2.4% increase in sales in the first half of 2025, and expected sales of over $57 billion in 2025 [9][10]. - The MedTech segment saw a 6.1% increase in sales in Q2 2025, driven by new acquisitions and product launches [12]. Group 2: Challenges and Headwinds - The company faces challenges from the loss of patent exclusivity for Stelara, which generated $10.36 billion in sales in 2024, leading to a 38.6% decline in sales in the first half of 2025 due to biosimilar competition [14][15]. - Sales in China are negatively impacted by the volume-based procurement program, which is expected to continue affecting sales in 2025 [13]. - Legal issues related to talc-based products and potential tariffs on pharmaceutical imports pose additional uncertainties for the company [17][20]. Group 3: Financial Outlook and Estimates - Johnson & Johnson's stock has outperformed the industry with a 26.0% increase year-to-date compared to a 1.6% increase for the industry [22]. - The Zacks Consensus Estimate for 2025 earnings has risen from $10.60 to $10.86 per share over the past 60 days, indicating positive sentiment [29]. - The company anticipates operational sales growth in both the Innovative Medicine and MedTech segments to be higher in the second half of 2025, with expectations for accelerated growth from 2026 onward [30][31].